Human Milk Oligosaccharides (HMOs) Sensitize Group B Streptococcus to Clindamycin, Erythromycin, Gentamicin, and Minocycline on a Strain Specific Basis

Human milk oligosaccharides (HMOs) possess antimicrobial and antibiofilm activity against Group B Streptococcus (GBS). HMOs were screened for their ability to potentiate antibiotic activity. We observed that HMOs potentiate the function of aminoglycosides, lincosamides, macrolides, and tetracyclines...

Full description

Saved in:
Bibliographic Details
Published in:ACS chemical biology 2018-08, Vol.13 (8), p.2020-2026
Main Authors: Craft, Kelly M, Gaddy, Jennifer A, Townsend, Steven D
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a408t-3945c8dadca78731c47104535b79b68227619e21ca56ccc567f616c3eb992b143
cites cdi_FETCH-LOGICAL-a408t-3945c8dadca78731c47104535b79b68227619e21ca56ccc567f616c3eb992b143
container_end_page 2026
container_issue 8
container_start_page 2020
container_title ACS chemical biology
container_volume 13
creator Craft, Kelly M
Gaddy, Jennifer A
Townsend, Steven D
description Human milk oligosaccharides (HMOs) possess antimicrobial and antibiofilm activity against Group B Streptococcus (GBS). HMOs were screened for their ability to potentiate antibiotic activity. We observed that HMOs potentiate the function of aminoglycosides, lincosamides, macrolides, and tetracyclines on a strain specific basis but not β-lactams or glycopeptides that inhibit cell wall synthesis. These findings are notable as GBS has evolved high levels of resistance toward aminoglycosides, macrolides, and tetracyclines. Finally, HMOs potentiate the function of aminoglycosides against both Staphylococcus aureus and Acinetobacter baumannii. On the basis of these observations, we hypothesized that HMOs act by increasing membrane permeability. This hypothesis was evaluated using a bacterial membrane permeability assay which revealed that HMOs increase membrane permeability toward propidium iodide.
doi_str_mv 10.1021/acschembio.8b00661
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2083725395</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2083725395</sourcerecordid><originalsourceid>FETCH-LOGICAL-a408t-3945c8dadca78731c47104535b79b68227619e21ca56ccc567f616c3eb992b143</originalsourceid><addsrcrecordid>eNp9kc1u2zAQhImiQZOmfYEeCh4ToHb4I5LisTESO0ACH9yehdWKrplKpEpKB_dF-rpRYje99bSzwDezWAwhnzibcyb4FWDGnetqH-dlzZjW_A0540oVs9JK8_ZVC3tK3uf8yFghdWnfkVPJmOFG6DPyZzV2EOiDb3_Sdet_xAyIO0i-cZlerB7W-ZJuXMh-8L8dXaY49vSabobk-iFiRBwzHSJdtD400O3Rhy_0Ju2HXYrHbenCAJ1_0RCa6VSIuMfJ4GgMFJ7DwAe66R36rUd6DdnnD-RkC212H4_znHy_vfm2WM3u18u7xdf7GRSsHGbSFgrLBhoEUxrJsTCcFUqq2thal0IYza0THEFpRFTabDXXKF1trah5Ic_JxSG3T_HX6PJQdT6ja1sILo65EqyURihp1YSKA4op5pzctuqT7yDtK86q50Kqf4VUx0Im0-dj_lh3rnm1_G1gAuYHYDJXj3FMYXr3f4lPu-mZ6g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2083725395</pqid></control><display><type>article</type><title>Human Milk Oligosaccharides (HMOs) Sensitize Group B Streptococcus to Clindamycin, Erythromycin, Gentamicin, and Minocycline on a Strain Specific Basis</title><source>Access via American Chemical Society</source><creator>Craft, Kelly M ; Gaddy, Jennifer A ; Townsend, Steven D</creator><creatorcontrib>Craft, Kelly M ; Gaddy, Jennifer A ; Townsend, Steven D</creatorcontrib><description>Human milk oligosaccharides (HMOs) possess antimicrobial and antibiofilm activity against Group B Streptococcus (GBS). HMOs were screened for their ability to potentiate antibiotic activity. We observed that HMOs potentiate the function of aminoglycosides, lincosamides, macrolides, and tetracyclines on a strain specific basis but not β-lactams or glycopeptides that inhibit cell wall synthesis. These findings are notable as GBS has evolved high levels of resistance toward aminoglycosides, macrolides, and tetracyclines. Finally, HMOs potentiate the function of aminoglycosides against both Staphylococcus aureus and Acinetobacter baumannii. On the basis of these observations, we hypothesized that HMOs act by increasing membrane permeability. This hypothesis was evaluated using a bacterial membrane permeability assay which revealed that HMOs increase membrane permeability toward propidium iodide.</description><identifier>ISSN: 1554-8929</identifier><identifier>EISSN: 1554-8937</identifier><identifier>DOI: 10.1021/acschembio.8b00661</identifier><identifier>PMID: 30071726</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>ACS chemical biology, 2018-08, Vol.13 (8), p.2020-2026</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a408t-3945c8dadca78731c47104535b79b68227619e21ca56ccc567f616c3eb992b143</citedby><cites>FETCH-LOGICAL-a408t-3945c8dadca78731c47104535b79b68227619e21ca56ccc567f616c3eb992b143</cites><orcidid>0000-0001-5362-7235 ; 0000-0001-9753-2801</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30071726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Craft, Kelly M</creatorcontrib><creatorcontrib>Gaddy, Jennifer A</creatorcontrib><creatorcontrib>Townsend, Steven D</creatorcontrib><title>Human Milk Oligosaccharides (HMOs) Sensitize Group B Streptococcus to Clindamycin, Erythromycin, Gentamicin, and Minocycline on a Strain Specific Basis</title><title>ACS chemical biology</title><addtitle>ACS Chem. Biol</addtitle><description>Human milk oligosaccharides (HMOs) possess antimicrobial and antibiofilm activity against Group B Streptococcus (GBS). HMOs were screened for their ability to potentiate antibiotic activity. We observed that HMOs potentiate the function of aminoglycosides, lincosamides, macrolides, and tetracyclines on a strain specific basis but not β-lactams or glycopeptides that inhibit cell wall synthesis. These findings are notable as GBS has evolved high levels of resistance toward aminoglycosides, macrolides, and tetracyclines. Finally, HMOs potentiate the function of aminoglycosides against both Staphylococcus aureus and Acinetobacter baumannii. On the basis of these observations, we hypothesized that HMOs act by increasing membrane permeability. This hypothesis was evaluated using a bacterial membrane permeability assay which revealed that HMOs increase membrane permeability toward propidium iodide.</description><issn>1554-8929</issn><issn>1554-8937</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u2zAQhImiQZOmfYEeCh4ToHb4I5LisTESO0ACH9yehdWKrplKpEpKB_dF-rpRYje99bSzwDezWAwhnzibcyb4FWDGnetqH-dlzZjW_A0540oVs9JK8_ZVC3tK3uf8yFghdWnfkVPJmOFG6DPyZzV2EOiDb3_Sdet_xAyIO0i-cZlerB7W-ZJuXMh-8L8dXaY49vSabobk-iFiRBwzHSJdtD400O3Rhy_0Ju2HXYrHbenCAJ1_0RCa6VSIuMfJ4GgMFJ7DwAe66R36rUd6DdnnD-RkC212H4_znHy_vfm2WM3u18u7xdf7GRSsHGbSFgrLBhoEUxrJsTCcFUqq2thal0IYza0THEFpRFTabDXXKF1trah5Ic_JxSG3T_HX6PJQdT6ja1sILo65EqyURihp1YSKA4op5pzctuqT7yDtK86q50Kqf4VUx0Im0-dj_lh3rnm1_G1gAuYHYDJXj3FMYXr3f4lPu-mZ6g</recordid><startdate>20180817</startdate><enddate>20180817</enddate><creator>Craft, Kelly M</creator><creator>Gaddy, Jennifer A</creator><creator>Townsend, Steven D</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5362-7235</orcidid><orcidid>https://orcid.org/0000-0001-9753-2801</orcidid></search><sort><creationdate>20180817</creationdate><title>Human Milk Oligosaccharides (HMOs) Sensitize Group B Streptococcus to Clindamycin, Erythromycin, Gentamicin, and Minocycline on a Strain Specific Basis</title><author>Craft, Kelly M ; Gaddy, Jennifer A ; Townsend, Steven D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a408t-3945c8dadca78731c47104535b79b68227619e21ca56ccc567f616c3eb992b143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Craft, Kelly M</creatorcontrib><creatorcontrib>Gaddy, Jennifer A</creatorcontrib><creatorcontrib>Townsend, Steven D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ACS chemical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Craft, Kelly M</au><au>Gaddy, Jennifer A</au><au>Townsend, Steven D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human Milk Oligosaccharides (HMOs) Sensitize Group B Streptococcus to Clindamycin, Erythromycin, Gentamicin, and Minocycline on a Strain Specific Basis</atitle><jtitle>ACS chemical biology</jtitle><addtitle>ACS Chem. Biol</addtitle><date>2018-08-17</date><risdate>2018</risdate><volume>13</volume><issue>8</issue><spage>2020</spage><epage>2026</epage><pages>2020-2026</pages><issn>1554-8929</issn><eissn>1554-8937</eissn><abstract>Human milk oligosaccharides (HMOs) possess antimicrobial and antibiofilm activity against Group B Streptococcus (GBS). HMOs were screened for their ability to potentiate antibiotic activity. We observed that HMOs potentiate the function of aminoglycosides, lincosamides, macrolides, and tetracyclines on a strain specific basis but not β-lactams or glycopeptides that inhibit cell wall synthesis. These findings are notable as GBS has evolved high levels of resistance toward aminoglycosides, macrolides, and tetracyclines. Finally, HMOs potentiate the function of aminoglycosides against both Staphylococcus aureus and Acinetobacter baumannii. On the basis of these observations, we hypothesized that HMOs act by increasing membrane permeability. This hypothesis was evaluated using a bacterial membrane permeability assay which revealed that HMOs increase membrane permeability toward propidium iodide.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>30071726</pmid><doi>10.1021/acschembio.8b00661</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-5362-7235</orcidid><orcidid>https://orcid.org/0000-0001-9753-2801</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1554-8929
ispartof ACS chemical biology, 2018-08, Vol.13 (8), p.2020-2026
issn 1554-8929
1554-8937
language eng
recordid cdi_proquest_miscellaneous_2083725395
source Access via American Chemical Society
title Human Milk Oligosaccharides (HMOs) Sensitize Group B Streptococcus to Clindamycin, Erythromycin, Gentamicin, and Minocycline on a Strain Specific Basis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T00%3A51%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20Milk%20Oligosaccharides%20(HMOs)%20Sensitize%20Group%20B%20Streptococcus%20to%20Clindamycin,%20Erythromycin,%20Gentamicin,%20and%20Minocycline%20on%20a%20Strain%20Specific%20Basis&rft.jtitle=ACS%20chemical%20biology&rft.au=Craft,%20Kelly%20M&rft.date=2018-08-17&rft.volume=13&rft.issue=8&rft.spage=2020&rft.epage=2026&rft.pages=2020-2026&rft.issn=1554-8929&rft.eissn=1554-8937&rft_id=info:doi/10.1021/acschembio.8b00661&rft_dat=%3Cproquest_cross%3E2083725395%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a408t-3945c8dadca78731c47104535b79b68227619e21ca56ccc567f616c3eb992b143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2083725395&rft_id=info:pmid/30071726&rfr_iscdi=true